GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Imagion Biosystems Ltd (ASX:IBX) » Definitions » 3-Year FCF Growth Rate

Imagion Biosystems (ASX:IBX) 3-Year FCF Growth Rate : -4.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Imagion Biosystems 3-Year FCF Growth Rate?

Imagion Biosystems's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-0.08.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -4.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 21.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 7 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Imagion Biosystems was 46.30% per year. The lowest was -4.00% per year. And the median was 28.30% per year.


Competitive Comparison of Imagion Biosystems's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, Imagion Biosystems's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imagion Biosystems's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Imagion Biosystems's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Imagion Biosystems's 3-Year FCF Growth Rate falls into.



Imagion Biosystems 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Imagion Biosystems  (ASX:IBX) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Imagion Biosystems 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Imagion Biosystems's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Imagion Biosystems (ASX:IBX) Business Description

Traded in Other Exchanges
N/A
Address
5601 Oberlin Drive, Suite 100, San Diego, CA, USA, 92121
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Imagion Biosystems (ASX:IBX) Headlines

No Headlines